Shuli Cheng
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A retrospective audit of the real-world safety and effectiveness profile of eptinezumab for treatment-resistant chronic migraine in Australia.
Journal: Headache
Published: June 15, 2025
Evidence-based guidelines for the pharmacological treatment of migraine.
Journal: Cephalalgia : an international journal of headache
Published: April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraine, summary version.
Journal: Cephalalgia : an international journal of headache
Published: April 25, 2025
Twelve-month efficacy of CGRP monoclonal antibodies and predictive value of short-term response: results of an Australian multicentre study.
Journal: BMJ neurology open
Published: September 27, 2023
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
Journal: The journal of headache and pain
Published: January 27, 2022
Intravenous Lidocaine and Ketamine Infusions for Headache Disorders: A Retrospective Cohort Study.
Journal: Frontiers in neurology
Published: December 23, 2021
Migraine management: an update for the 2020s.
Journal: Internal medicine journal
Published: October 19, 2021
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men.
Journal: Frontiers in neurology
Published: September 11, 2021
Liquid Levodopa/Carbidopa: Old Solution, Forgotten Complication.
Journal: Journal of movement disorders
Published: April 20, 2017
Non-convulsive status epilepticus in the elderly.
Journal: Epileptic disorders : international epilepsy journal with videotape
Published: December 16, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026